E-Book | June 22, 2021

A Critical Analysis Of Outsourcing In A Time Of Turmoil

Source: Outsourced Pharma
21_06_OP_OutsourcingTurmoil_Ebook_450x300

What happens when your drug development and manufacturing outsourcing activities are impacted by an unusually tight and publicized nexus between national and international politics, and the pursuit of science in our pharmaceutical industry? In this second of two editorial collections, Chief Editor Louis Garguilo helps readers work through some answers, and look critically at how we’ve become front-page news. But be forewarned: “follow the science” may turn out to have a meaning quite different than what you expect.

You might also like:

VIEW THE E-BOOK!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Outsourced Pharma? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: